Blackstone Mortgage Trust president sells $20,091 in BXMT stock
Source: Investing.com

Blackstone Mortgage Trust President Fernando Austin Pena sold 1,725 shares for $20,091 at roughly $11.65 per share under prearranged Rule 10b5-1 plans, solely to cover tax withholding on vested restricted stock. BXMT trades near its 52-week low at $11.30 and is down 35% over six months; Q2 distributable earnings of $0.31 per share missed the $0.42 consensus despite revenue of $158.06M exceeding the $127.34M forecast. Book value per share fell 4% to $19.31, Raymond James downgraded the stock over portfolio-quality concerns, and management expects continued near-term earnings pressure.
Analysis
The insider sale is non-informative: it was pre-scheduled and tax-related, so the investable issue is dividend coverage and the path of credit marks. At roughly 0.58x reported book value, BXMT already discounts meaningful future losses, but distributable earnings running below the quarterly dividend creates a binary 1-3 month catalyst around the next earnings release and board capital-allocation decision. A dividend reset would likely remove the yield-support buyer base and could drive a further 10-20% equity decline even if the underlying loan book stabilizes.
Portfolio rotation toward more defensive property types may lower eventual loss severity, but repayments also create reinvestment drag: capital returned from legacy loans must be redeployed into a more competitive private-credit market, potentially at lower levered returns. Rate cuts are not automatically positive for BXMT; lower floating-rate loan coupons can compress net interest income faster than funding costs decline, depending on interest-rate floors and hedge positioning. The more relevant 6-18 month variable is whether CRE transaction volumes reopen sufficiently to permit repayments/refinancings without forced collateral sales.
The contrarian case is that the discount to book value and embedded dividend-cut risk are already substantial, while reserve formation peaks before actual realized losses do. That thesis requires independently verifiable evidence of stable book value, declining criticized-loan migration, and a recovery in dividend coverage—not merely a lower watchlist balance. Peers with more diversified earnings streams, particularly STWD, should retain a valuation and funding advantage if CRE stress persists.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment
Key Decisions for Investors
- Maintain an underweight/avoid stance on BXMT into the next earnings release; do not treat the 16% yield as carry income until distributable earnings cover the dividend. Bear thesis is validated by another book-value decline above 2% or distributable earnings below $0.35/share; it is falsified by two quarters of coverage at or above the dividend with reserves stabilizing.
- For CRE-credit exposure, pair long STWD / short BXMT over a 3-6 month horizon, sized beta-neutral. The trade captures diversification and funding-quality dispersion; stop out if BXMT reports stable book value and dividend coverage while STWD shows incremental credit deterioration.
- If liquid BXMT options are available, prefer 3-6 month put spreads rather than an outright short because the dividend creates meaningful borrow/carry risk. A downside structure targeting a post-dividend-reset move toward 0.45-0.50x book offers better-defined risk than chasing shares near the current low.
- Set an entry alert for a contrarian BXMT long only after the next report confirms book value erosion below 1%, no material new non-accrual migration, and distributable earnings above $0.40/share. Without those data points, the apparent discount is more likely compensation for unresolved credit and payout risk than a catalyst-driven value opportunity.
More News
- Liquidia stock price target cut to $58 by H.C. Wainwright on patent uncertainty
- Wells Fargo cuts Liquidia stock rating on patent ruling concerns
- Draftkings stock hits 52-week low at 18.55 USD
- Stifel reiterates SpyGlass Pharma stock Buy rating on acquisition
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Stocks remain under the thrall of higher yields and higher oil. Here's what's ahead
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Automating Financial Model Updates: A Source-Controlled Workflow
- Weekly Update: Live Event Center, In-App Documents, and Faster Transcripts